Synthetic Endovascular Repair Systems to Top $2 Billion by 2013, Says Greystone Research

(Amherst, NH) – The global market for synthetic endovascular repair (SER) systems will grow at an average annual rate of seventeen percent over the next four years and will exceed $ 2 billion in 2013, according to the latest estimates from Greystone Research Associates. While abdominal aortic aneurysms account for about 90 percent of all procedures, repair of thoracic aortic aneurysms (TAA) is the fastest growing application segment for SER.

“The incidence of TAA has increased more than three-fold in the past 40 years, partly because it is being identified more often than in the past by computed tomography (CT) of the chest, which is now more widely used to screen for other medical conditions,” explains George Perros, Greystone Research Managing Director. “Most non-leaking TAAs are detected by tests such as chest x-ray or CT scan done for other reasons.”

Because of their often asymptomatic nature and the high mortality risk associated with their sudden failure, vascular defects are often considered to be an undertreated disease segment. As endovascular graft design evolves, clinicians are benefiting from a flow of incremental improvements that address real-world issues uncovered in the OR and cath lab. New products are helping clinicians deal with challenging anatomic features, such as tortuosity and implantation site compromise, and challenging locations.

A report from Greystone Research Associates examines the key demand, economic and competitive factors that will determine the future direction of the endovascular repair segment. Greystone’s Synthetic Endovascular Repair Systems (http://greystoneassociates.org/Reports/Cardiology/EVR/Synthetic_Endovascular_Repair_Systems.htm) study includes assessments of commercial endovascular graft systems, analysis of the key players in this segment, and forecasts to 2013.

More information is available at www.greystoneassociates.org .


Source: Greystone Research Associates

About Greystone

Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

Contact:

Mark Smith
Greystone Research Associates
98 Route 101A
Amherst, NH 03031 USA
Voice: 603-595-4340
Fax: 603-804-0466
www.greystoneassociates.org

This release was published on openPR.